Drug Profile
Research programme: influenza virus vaccine liposomal - Xenetic Biosciences
Alternative Names: Liposomal influenza vaccine - Xenetic BiosciencesLatest Information Update: 27 Nov 2014
Price :
$50
*
At a glance
- Originator Lipoxen Technologies
- Developer Xenetic Biosciences
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 27 Nov 2014 No development reported - Preclinical for Influenza virus infections in USA (Parenteral)
- 08 Sep 2011 Lipoxen is now called Xenetic Biosciences